2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level

Saved in:
Bibliographic Details
Published in:Open forum infectious diseases 2022-12, Vol.9 (Supplement_2)
Main Authors: Comeaux, Christy A, Falsey, Ann R, Williams, Kristi, Bart, Stephan, Ervin, John E, Bastian, Arangassery R, Menten, Joris, De Paepe, Els, Vandenberghe, Sjouke, Chan, Eric K H, Sadoff, Jerald, Douoguih, Macaya, Callendret, Benoit, Heijnen, Esther
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1302-94976c8d71cc0c3e891bf27c341705deb1a8c440db2bbd2806d7e552069bc9e73
cites
container_end_page
container_issue Supplement_2
container_start_page
container_title Open forum infectious diseases
container_volume 9
creator Comeaux, Christy A
Falsey, Ann R
Williams, Kristi
Bart, Stephan
Ervin, John E
Bastian, Arangassery R
Menten, Joris
De Paepe, Els
Vandenberghe, Sjouke
Chan, Eric K H
Sadoff, Jerald
Douoguih, Macaya
Callendret, Benoit
Heijnen, Esther
description
doi_str_mv 10.1093/ofid/ofac492.152
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_ofid_ofac492_152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_ofid_ofac492_152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1302-94976c8d71cc0c3e891bf27c341705deb1a8c440db2bbd2806d7e552069bc9e73</originalsourceid><addsrcrecordid>eNpNkMtqwzAQRUVpoSHNvkv9gJ2RZFvWMoSmLQQKfW2NXk7VxnKQnIA3_fbKJItu7hxmLrM4CN0TyAkItuxbZ1JIXQiak5JeoRlltM5qUfLrf3yLFjF-AwAhUAIXM_SbbiTH297vssGGDruuO_p-Z73Tbhhx3-KVoVX--vaZH4LdLBPgCVL0g3Uen6TWzlssd9L5OOCpkNYSH75ktJgqHIejGbEaUyXVvMHBxR-8tye7v0M3rdxHu7jMOfrYPLyvn7Lty-PzerXNNGFAM1EIXunacKI1aGZrQVRLuWYF4VAaq4isdVGAUVQpQ2uoDLdlSaESSgvL2RzB-a8OfYzBts0huE6GsSHQTAqbSWFzUdgkhewPuJhk7A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level</title><source>Open Access: Oxford University Press Open Journals</source><source>PubMed Central</source><creator>Comeaux, Christy A ; Falsey, Ann R ; Williams, Kristi ; Bart, Stephan ; Ervin, John E ; Bastian, Arangassery R ; Menten, Joris ; De Paepe, Els ; Vandenberghe, Sjouke ; Chan, Eric K H ; Sadoff, Jerald ; Douoguih, Macaya ; Callendret, Benoit ; Heijnen, Esther</creator><creatorcontrib>Comeaux, Christy A ; Falsey, Ann R ; Williams, Kristi ; Bart, Stephan ; Ervin, John E ; Bastian, Arangassery R ; Menten, Joris ; De Paepe, Els ; Vandenberghe, Sjouke ; Chan, Eric K H ; Sadoff, Jerald ; Douoguih, Macaya ; Callendret, Benoit ; Heijnen, Esther</creatorcontrib><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofac492.152</identifier><language>eng</language><ispartof>Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1302-94976c8d71cc0c3e891bf27c341705deb1a8c440db2bbd2806d7e552069bc9e73</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Comeaux, Christy A</creatorcontrib><creatorcontrib>Falsey, Ann R</creatorcontrib><creatorcontrib>Williams, Kristi</creatorcontrib><creatorcontrib>Bart, Stephan</creatorcontrib><creatorcontrib>Ervin, John E</creatorcontrib><creatorcontrib>Bastian, Arangassery R</creatorcontrib><creatorcontrib>Menten, Joris</creatorcontrib><creatorcontrib>De Paepe, Els</creatorcontrib><creatorcontrib>Vandenberghe, Sjouke</creatorcontrib><creatorcontrib>Chan, Eric K H</creatorcontrib><creatorcontrib>Sadoff, Jerald</creatorcontrib><creatorcontrib>Douoguih, Macaya</creatorcontrib><creatorcontrib>Callendret, Benoit</creatorcontrib><creatorcontrib>Heijnen, Esther</creatorcontrib><title>2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level</title><title>Open forum infectious diseases</title><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpNkMtqwzAQRUVpoSHNvkv9gJ2RZFvWMoSmLQQKfW2NXk7VxnKQnIA3_fbKJItu7hxmLrM4CN0TyAkItuxbZ1JIXQiak5JeoRlltM5qUfLrf3yLFjF-AwAhUAIXM_SbbiTH297vssGGDruuO_p-Z73Tbhhx3-KVoVX--vaZH4LdLBPgCVL0g3Uen6TWzlssd9L5OOCpkNYSH75ktJgqHIejGbEaUyXVvMHBxR-8tye7v0M3rdxHu7jMOfrYPLyvn7Lty-PzerXNNGFAM1EIXunacKI1aGZrQVRLuWYF4VAaq4isdVGAUVQpQ2uoDLdlSaESSgvL2RzB-a8OfYzBts0huE6GsSHQTAqbSWFzUdgkhewPuJhk7A</recordid><startdate>20221215</startdate><enddate>20221215</enddate><creator>Comeaux, Christy A</creator><creator>Falsey, Ann R</creator><creator>Williams, Kristi</creator><creator>Bart, Stephan</creator><creator>Ervin, John E</creator><creator>Bastian, Arangassery R</creator><creator>Menten, Joris</creator><creator>De Paepe, Els</creator><creator>Vandenberghe, Sjouke</creator><creator>Chan, Eric K H</creator><creator>Sadoff, Jerald</creator><creator>Douoguih, Macaya</creator><creator>Callendret, Benoit</creator><creator>Heijnen, Esther</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221215</creationdate><title>2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level</title><author>Comeaux, Christy A ; Falsey, Ann R ; Williams, Kristi ; Bart, Stephan ; Ervin, John E ; Bastian, Arangassery R ; Menten, Joris ; De Paepe, Els ; Vandenberghe, Sjouke ; Chan, Eric K H ; Sadoff, Jerald ; Douoguih, Macaya ; Callendret, Benoit ; Heijnen, Esther</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1302-94976c8d71cc0c3e891bf27c341705deb1a8c440db2bbd2806d7e552069bc9e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Comeaux, Christy A</creatorcontrib><creatorcontrib>Falsey, Ann R</creatorcontrib><creatorcontrib>Williams, Kristi</creatorcontrib><creatorcontrib>Bart, Stephan</creatorcontrib><creatorcontrib>Ervin, John E</creatorcontrib><creatorcontrib>Bastian, Arangassery R</creatorcontrib><creatorcontrib>Menten, Joris</creatorcontrib><creatorcontrib>De Paepe, Els</creatorcontrib><creatorcontrib>Vandenberghe, Sjouke</creatorcontrib><creatorcontrib>Chan, Eric K H</creatorcontrib><creatorcontrib>Sadoff, Jerald</creatorcontrib><creatorcontrib>Douoguih, Macaya</creatorcontrib><creatorcontrib>Callendret, Benoit</creatorcontrib><creatorcontrib>Heijnen, Esther</creatorcontrib><collection>CrossRef</collection><jtitle>Open forum infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Comeaux, Christy A</au><au>Falsey, Ann R</au><au>Williams, Kristi</au><au>Bart, Stephan</au><au>Ervin, John E</au><au>Bastian, Arangassery R</au><au>Menten, Joris</au><au>De Paepe, Els</au><au>Vandenberghe, Sjouke</au><au>Chan, Eric K H</au><au>Sadoff, Jerald</au><au>Douoguih, Macaya</au><au>Callendret, Benoit</au><au>Heijnen, Esther</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level</atitle><jtitle>Open forum infectious diseases</jtitle><date>2022-12-15</date><risdate>2022</risdate><volume>9</volume><issue>Supplement_2</issue><issn>2328-8957</issn><eissn>2328-8957</eissn><doi>10.1093/ofid/ofac492.152</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2328-8957
ispartof Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)
issn 2328-8957
2328-8957
language eng
recordid cdi_crossref_primary_10_1093_ofid_ofac492_152
source Open Access: Oxford University Press Open Journals; PubMed Central
title 2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A56%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=2321.%20Long-term%20immunogenicity%20of%20Ad26.RSV.preF/RSV%20preF%20protein%20vaccine%20against%20RSV%20in%20a%20phase%202b%20study%20by%20age%20and%20risk%20level&rft.jtitle=Open%20forum%20infectious%20diseases&rft.au=Comeaux,%20Christy%20A&rft.date=2022-12-15&rft.volume=9&rft.issue=Supplement_2&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofac492.152&rft_dat=%3Ccrossref%3E10_1093_ofid_ofac492_152%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1302-94976c8d71cc0c3e891bf27c341705deb1a8c440db2bbd2806d7e552069bc9e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true